期刊
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA
卷 20, 期 1, 页码 105-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.soc.2010.09.001
关键词
Melanoma; Adjuvant therapy; Interferon; Vaccines; GM-CSF; Ipilimumab
Adjuvant therapy is commonly used in melanoma because recurrence after surgery usually results in the patient's eventual death. Surgeons have a profound influence on patients' decisions regarding adjuvant therapy, beginning with providing a clear understanding of the risk of specific types of recurrence. This review summarizes the potential oncologic benefits and relevant toxicities of adjuvant systemic therapies for melanoma that are currently available and under investigation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据